Ouster of FDA’s Peter Marks alarms a biopharma industry that saw him as an ally Move by health secretary RFK Jr. appears to put companies’ interests further at risk

https://www.statnews.com/2025/03/29/fda-peter-marks-ouster-alarms-biopharma-that-saw-him-as-ally/